Product image of Iomeron (Iomeprol) supplied by GNH India

Iomeron

Active Ingredient:
Iomeprol
Origin:
EU

Iomeron (Iomeprol)

Iomeprol, the active ingredient in Iomeron, is an iodinated contrast media presented as a solution for injection for intraarterial, intraarticular, and intravenous use. It provides radiodensity enhancement that facilitates clear visualization of vascular and tissue structures during diagnostic imaging procedures such as angiography, arthrography, computed tomography and other vascular imaging studies.

GNH India supplies Iomeron as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable logistics for global distribution.

Manufacturer / TM Owner

Bracco Imaging S.P.A.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Iomeron, an iodinated contrast agent, enhances radiographic visualization in several diagnostic imaging procedures.
  • Angiography: improves delineation of blood vessels for accurate assessment.
  • Arthrography: highlights joint spaces to aid evaluation of cartilage and ligaments.
  • Computed tomography (CT) imaging: increases tissue contrast for detailed cross‑sectional images.
  • Vascular imaging procedures: accentuates vascular anatomy for precise diagnosis.

How It Works

  • Iomeprol contains a high density of iodine atoms that strongly absorb X‑ray photons. When administered intra‑vascularly or intra‑articularly, the iodine atoms increase the radiodensity of the blood or joint space, creating a contrast between the enhanced area and surrounding tissues. This differential attenuation allows imaging systems to generate clearer images of vascular structures, organ parenchyma, and joint components during angiography, CT and related procedures.

Side Effects

Iomeron may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

  • Warm sensation or flushing: transient feeling of heat during injection.
  • Metallic taste: brief alteration of taste perception.
  • Nausea: mild upset stomach.
  • Headache: mild to moderate pain.

Serious or Rare Side Effects

  • Anaphylactic reaction: severe allergic response requiring immediate treatment.
  • Renal toxicity: impaired kidney function, especially in patients with pre‑existing renal disease.
  • Severe hypotension: sudden drop in blood pressure.
  • Cardiac arrhythmia: irregular heart rhythm.

Precautions & Warnings

When using Iomeron, several precautions should be observed to minimize risk and ensure patient safety.

  • Assess renal function: evaluate eGFR before administration in patients with kidney disease.
  • Review allergy history: avoid use in individuals with prior severe reactions to iodinated contrast.
  • Ensure adequate hydration: provide sufficient fluids before and after the procedure to support renal clearance.
  • Use the lowest effective volume: limit contrast dose to the minimum required for diagnostic quality.
  • Monitor vital signs: observe patients during and after injection for signs of hypotension or allergic response.
  • Store at ambient temperature: keep in original container, protect from light and moisture, and do not freeze.

Avoid Interactions

Iomeron can interact with certain medications, influencing safety or efficacy.

Major Interactions (Avoid)

  • Nephrotoxic drugs (e.g., aminoglycosides, NSAIDs): increase risk of renal impairment.
  • Metformin: may precipitate lactic acidosis in patients with reduced renal function after contrast exposure.
  • Iodine‑containing pharmaceuticals (e.g., amiodarone): add to total iodine load.

Moderate Interactions (Monitor Closely)

  • Diuretics: affect fluid balance and may potentiate contrast‑induced nephropathy.
  • ACE inhibitors or ARBs: may alter renal hemodynamics, requiring monitoring of kidney function.

Frequently Asked Questions

Iomeron is an iodinated contrast agent used to improve the visibility of blood vessels, joints and internal organs during diagnostic imaging procedures such as angiography, computed tomography (CT) scans and other vascular imaging studies.

Iomeprol contains a high concentration of iodine atoms that absorb X‑ray photons. When injected, the iodine increases the radiodensity of the targeted area, creating a contrast difference that allows imaging equipment to produce clearer, more detailed pictures of anatomical structures.

The dose of Iomeron is set by the prescribing physician based on the specific imaging protocol, the patient’s body weight, renal function and the area to be visualized. No standard dosing can be provided without a medical assessment.

Limited safety data exist for Iomeron during pregnancy and lactation. It is generally avoided unless the diagnostic benefit outweighs potential risks, and the decision should be made by the treating physician in consultation with the patient.

To order Iomeron, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Iomeron is a non‑ionic, low‑osmolality iodinated contrast medium similar to agents such as Iohexol. It offers comparable image quality with a favorable safety profile, though individual patient factors and institutional preferences may guide the choice of one agent over another.

Iomeron should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the solution from direct light, moisture and freezing. Do not shake the vial vigorously; handle according to standard aseptic injection‑solution procedures.

Iomeron is supplied as a sterile solution for injection and is administered by a qualified healthcare professional via intra‑arterial, intra‑articular or intravenous routes, depending on the imaging study being performed.

The most serious risks include severe allergic reactions such as anaphylaxis, contrast‑induced nephropathy leading to renal impairment, sudden hypotension, and cardiac arrhythmias. Prompt medical attention is required if any of these events occur.

Iomeron should be avoided in patients with a known severe hypersensitivity to iodinated contrast media, those with uncontrolled hyperthyroidism, severe renal impairment (eGFR < 30 mL/min/1.73 m²), or in individuals where the diagnostic benefit does not outweigh the potential risks.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.